DAA39 |
cholecystokinin |
CCK |
6.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA40 |
cholecystokinin B receptor |
CCKBR |
11.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA448 |
chromatin modifying protein 2A |
CHMP2A |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA364 |
chromobox homolog 7 |
CBX7 |
4.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA478 |
chromosome 11 open reading frame 73 |
C11orf73 |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2110 |
chromosome 12 open reading frame 35 increases with age |
KIAA1551 |
71.0% Increase Gene Expression Level |
ovary |
Human |
|
DAA2390 |
chromosome 14 open reading frame 177 decreases with age |
C14orf177 |
16.2% Decrease DNA Methylation |
dermis |
Human |
|
DAA309 |
chromosome 14 open reading frame 2 |
C14orf2 |
2.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA504 |
chromosome 16 open reading frame 61 |
C16orf61 |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA342 |
chromosome 18 open reading frame 19 |
C18orf19 |
5.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA291 |
chromosome 1 open reading frame 162 |
C1orf162 |
37.0% Increase Gene Expression Level |
kidney |
Human |
|
DAA27 |
chromosome 1 open reading frame 95 |
C1orf95 |
5.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA385 |
chromosome 2 open reading frame 88 |
C2orf88 |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA480 |
chromosome 4 open reading frame 17 |
C4orf17 |
13.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2126 |
chromosome 4 open reading frame 34 decreases with age |
SMIM14 |
35.9% Decrease Gene Expression Level |
ovary |
Human |
|
DAA28 |
chromosome 5 open reading frame 13 |
C5orf13 |
8.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA124 |
chromosome 5 open reading frame 30 |
C5orf30 |
19.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA29 |
chromosome 6 open reading frame 106 |
C6orf106 |
12.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA358 |
chromosome 6 open reading frame 136 |
C6orf136 |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA404 |
chromosome 7 open reading frame 44 |
C7orf44 |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA506 |
chromosome 9 open reading frame 123 |
C9orf123 |
2.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA552 |
chromosome X open reading frame 57 |
CXorf57 |
35.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA2055 |
Circulating miR-21 expression increases |
— |
— |
blood |
Human |
|
DAA426 |
citrate lyase beta like |
CLYBL |
6.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA263 |
claudin 8 |
CLDN8 |
17.0% Decrease Gene Expression Level |
kidney |
Human |
|